Near-Infrared Optical Nanosensors for Continuous Detection of Glucose
- PMID: 31709808
- PMCID: PMC7196875
- DOI: 10.1177/1932296819886928
Near-Infrared Optical Nanosensors for Continuous Detection of Glucose
Abstract
Background: Continuous glucose monitors (CGMs) enable people with diabetes to proactively manage their blood glucose and reduce the risk of hypoglycemia. Commercially available CGMs utilize percutaneous electrodes that, after days to weeks of implantation, are subjected to the foreign body response that severely reduces sensor accuracy. The previous work demonstrated the use of hydrogels containing a glucose-responsive viologen that quenches a nearby fluorophore. Here, we investigate the immobilization of this sensing motif onto a nanoparticle surface and optimize local surface concentrations for optical glucose sensing.
Methods: A viologen quencher-fluorescent dye system was incorporated into poly(2-hydroethyl methacrylate) hydrogels in varying quantities to assess the effect of quencher-fluorophore concentration on glucose responsiveness. The sensing motif was then immobilized onto silica nanoparticles by carbodiimide chemistry. Nanosensors with a range of dye and quencher concentrations were challenged for glucose responsiveness to determine the optimal sensor formulation.
Results: When incorporated into a hydrogel, high concentrations of viologen quencher and fluorophore were required to permit electron transfer between the two components and yield a detectable glucose response. Immobilization of this glucose-responsive system onto a silica nanoparticle facilitated this electron transfer to yield detectable responses at even low concentrations. Increasing quencher concentration on the nanoparticle, relative to the fluorophore, resulted in the greatest apparent glucose response.
Conclusion: The nanoparticle sensors demonstrated excellent glucose response in the physiological range and are a promising tool for real-time glucose tracking.
Keywords: CGM; fluorescence; glucose sensors; implantable; subcutaneous.
Conflict of interest statement
Figures






References
-
- Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2017. Atlanta, GA: CDC.
-
- Bindra DS, Zhang Y, Wilson GS, et al. Design and in vitro studies of a needle-type glucose sensor for subcutaneous monitoring. Anal Chem. 1991;63(17):1692-1696. - PubMed
-
- Klonoff DC. Continuous glucose monitoring: roadmap for 21st century diabetes therapy. Diabetes Care. 2005;28(5):1231-1239. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical